Date: 2025/06/07 - 05:00
GLP-1 drugs like Ozempic are associated with a higher risk of developing wet age-related macular degeneration in people with type 2 diabetes, according to a new study. The risk increased the longer people were prescribed a GLP-1 drug, particularly those containing semaglutide.
Date: 2025/06/05 - 00:00
An anti-inflammatory diet may be beneficial for colon cancer survivors, according to a new clinical trial. People who adhered an anti-inflammatory diet had longer overall survival rates than those who followed a pro-inflammatory diet.
Date: 2025/06/04 - 00:32
Researchers report that a three-year exercise program helped improve survival rates for people who have been treated for colon cancer. The findings could be helpful for doctors recommending exercise as part of a post-cancer regimen.
Date: 2025/05/28 - 23:32
'Fibermaxxing,' TikTok's latest nutrition trend, emphasizes fiber intake during meals and snacks, which could aid weight loss and help lower the risk of chronic diseases. But a high fiber diet may not be suitable for older adults and people with certain health conditions.
Date: 2025/05/19 - 22:32
Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly. Participants who received tirzepatide also had greater improvements in metabolic risk factors. Tirzepatide's dual effects on GLP-1 and GIP may explain its superior performance.
Date: 2025/05/15 - 23:32
Federal regulators have accepted Novo Nordisk’s application to produce a pill version of its injectable weight-loss medication Wegovy. Experts say an oral medication for weight loss might be more cost effective and easier for people to use.